Showing 221 - 240 results of 8,153 for search '"tumors"', query time: 0.08s Refine Results
  1. 221

    Two Synchronous Neonatal Tumors: An Extremely Rare Case by M. Rodríguez-Zubieta, K. Albarenque, C. Lagues, A. San Roman, M. Varela, D. Russo, G. Podesta, D. Steinberg, C. Schauvinhold, A. Etchegaray, M. T. G. de Dávila

    Published 2021-01-01
    “…Our patient had a large facial tumor associated with extremely high alpha-fetoprotein levels. …”
    Get full text
    Article
  2. 222
  3. 223

    Progress of Clinical Research on Trop2 in Solid Tumors by Ying ZHANG, Yueping LIU

    Published 2025-01-01
    “…Trophoblast cell surface antigen 2 (Trop2) is a glycoprotein that is barely expressed in normal tissues but highly expressed in malignant tumors; it is remarkably associated with poor prognosis. …”
    Get full text
    Article
  4. 224

    Percutaneous cryoablation of kidney tumors after partial nephrectomy by Wojciech Krajewski, Maciej Guziński, Wojciech Tomczak, Łukasz Nowak, Jan Łaszkiewicz, Joanna Chorbińska, Adam Chełmoński, Katarzyna Grunwald, Bartosz Małkiewicz, Tomasz Szydełko

    Published 2024-10-01
    “…Materials and methods: We conducted a retrospective data analysis to evaluate patients treated with PCA for tumor recurrence or residual disease in the postresection bed, excluding those with de novo or recurrent tumors in the contralateral kidney. …”
    Get full text
    Article
  5. 225

    Gastric Collision Tumors: An Insight into Their Origin and Clinical Significance by Adamantios Michalinos, Anastasia Constantinidou, Michael Kontos

    Published 2015-01-01
    “…They are rare entities with only 63 cases described in English literature. Tumors encountered are gastric adenocarcinomas colliding with lymphomas, gastrointestinal stromal tumors, squamous cell carcinomas, and neuroendocrine tumors. …”
    Get full text
    Article
  6. 226

    The Immune Response to Tumors as a Tool toward Immunotherapy by F. Pandolfi, R. Cianci, D. Pagliari, F. Casciano, C. Bagalà, A. Astone, R. Landolfi, C. Barone

    Published 2011-01-01
    “…Herein we will review some of the recent achievement of immunotherapy in such aggressive cancers as melanoma, prostatic cancer, colorectal carcinoma, and hematologic malignancies. Immunotherapy of tumors has developed several techniques: immune cell transfer, vaccines, immunobiological molecules such as monoclonal antibodies that improve the immune responses to tumors. …”
    Get full text
    Article
  7. 227

    The Advantage of PET and CT Integration in Examination of Lung Tumors by Guangming Lu, Zhongqiu Wang, Hong Zhu, Linfeng Chang, Yingxin Chen, Jiang Wu, Yane Zhao

    Published 2007-01-01
    “…The examination of lung tumor can be further specified by the correlation between the size of pulmonary malignant neoplasm and the ROI's SUVmax.…”
    Get full text
    Article
  8. 228
  9. 229

    High prevalence of p16 staining in malignant tumors. by Noémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, Andreas M Luebke, Martina Kluth, Franziska Büscheck, Claudia Hube-Magg, Doris Höflmayer, Natalia Gorbokon, Sören Weidemann, Katharina Möller, Christoph Fraune, Christian Bernreuther, Ronald Simon, Christian Kähler, Anne Menz, Andrea Hinsch, Frank Jacobsen, Patrick Lebok, Till Clauditz, Guido Sauter, Ria Uhlig, Waldemar Wilczak, Stefan Steurer, Eike Burandt, Rainer Krech, David Dum, Till Krech, Andreas Marx, Sarah Minner

    Published 2022-01-01
    “…However, the prevalence of p16 expression in different cancer types is controversial. 15,783 samples from 124 different tumor types and 76 different normal tissue types were analyzed by immunohistochemistry in a tissue microarray format. p16 was detectable in 5,292 (45.0%) of 11,759 interpretable tumors. …”
    Get full text
    Article
  10. 230

    Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors by Qing Li, Yonghao Li, Ximei Sun, Xinlei Zhang, Mei Zhang

    Published 2022-01-01
    “…Background. Parathyroid tumors are common endocrine neoplasias associated with primary hyperparathyroidism. …”
    Get full text
    Article
  11. 231
  12. 232

    Hepatic Arterial Embolization for the Treatment of Metastatic Neuroendocrine Tumors by Eric Lee, H. Leon Pachter, Umut Sarpel

    Published 2012-01-01
    “…Neuroendocrine tumors (NETs) have a high predilection for metastasizing to the liver and can cause severe debilitating symptoms adversely affecting quality of life. …”
    Get full text
    Article
  13. 233
  14. 234

    A Pleural Solitary Fibrous Tumor, Multiple Gastrointestinal Stromal Tumors, Moyamoya Disease, and Hyperparathyroidism in a Patient Associated with NF1 by Yoko Yamamoto, Ken Kodama, Shigekazu Yokoyama, Masashi Takeda, Shintaro Michishita

    Published 2015-01-01
    “…Loss of the gene function, due to a point mutation, leads to an increase in cell proliferation and the development of several tumors. We report a 60-year-old female patient manifesting hypercalcemia due to hyperparathyroidism, a solitary fibrous tumor (SFT) of the pleura, multiple gastrointestinal stromal tumors (GISTs), and moyamoya disease associated with NF1. …”
    Get full text
    Article
  15. 235

    Comprehensive single-cell atlas of colorectal neuroendocrine tumors with liver metastases: unraveling tumor microenvironment heterogeneity between primary lesions and metastases by Yiqiao Deng, Qichen Chen, Chengyao Guo, Jinghua Chen, Xin Li, Zhiyu Li, Yefan Zhang, Jianjun Zhao, Jianguo Zhou, Jianqiang Cai, Tao Yan, Xiaobing Wang, Xinyu Bi, Zhen Huang, Hong Zhao

    Published 2025-01-01
    “…Abstract Background Colorectal neuroendocrine tumors with liver metastases (CRNELM) are associated with a poorer prognosis compared to their nonmetastatic counterparts. …”
    Get full text
    Article
  16. 236

    Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction by Francesco Verona, Sebastiano Di Bella, Roberto Schirano, Camilla Manfredi, Francesca Angeloro, Giulia Bozzari, Matilde Todaro, Matilde Todaro, Giuseppe Giannini, Giuseppe Giannini, Giorgio Stassi, Veronica Veschi

    Published 2025-02-01
    “…Cancer stem cells (CSCs) are a small subset within the tumor mass significantly contributing to cancer progression through dysregulation of various oncogenic pathways, driving tumor growth, chemoresistance and metastasis formation. …”
    Get full text
    Article
  17. 237
  18. 238
  19. 239
  20. 240